SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Tideman S)
 

Sökning: WFRF:(Tideman S) > Neurodevelopmental ...

  • Liu, S. X.Karolinska Institutet (författare)

Neurodevelopmental Disorders, Glycemic Control, and Diabetic Complications in Type 1 Diabetes: a Nationwide Cohort Study

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2021-06-25
  • Cary, NC :The Endocrine Society,2021

Nummerbeteckningar

  • LIBRIS-ID:oai:gup.ub.gu.se/312197
  • https://gup.ub.gu.se/publication/312197URI
  • https://doi.org/10.1210/clinem/dgab467DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-92681URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-45915URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:148146576URI

Kompletterande språkuppgifter

  • Språk:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding agency:Karolinska Institutet, Strategic Research Program in Neuroscience (StratNeuro)
  • Funding: The Swedish Research Council (No 2017-00788), Stockholm Region Council (No 20180718) and Karolinska Institutet, Strategic Research Program in Neuroscience (StratNeuro).
  • Context: Neurodevelopmental disorders are more prevalent in childhood-onset type 1 diabetes than in the general population, and the symptoms may limit the individual's ability for diabetes management. Objective: This study investigated whether comorbid neurodevelopmental disorders are associated with long-term glycemic control and risk of diabetic complications. Methods: This population-based cohort study used longitudinally collected data from Swedish registers. We identified 11 326 individuals born during 1973-2013, diagnosed with type 1 diabetes during 1990-2013 (median onset age: 9.6 years). Among them, 764 had a comorbid neurodevelopmental disorder, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, and intellectual disability. We used multinomial logistic regression to calculate odds ratios (ORs) of having poor glycemic control (assessed by glycated hemoglobin [HbA(1c)]) and Cox regression to estimate hazard ratios (HRs) of nephropathy and retinopathy. Results: The median follow-up was 7.5 years (interquartile range [IQR] 3.9, 11.2). Having any neurodevelopmental disorder (ORadjusted 1.51 [95% CI 1.13, 2.03]), or ADHD (ORadjusted 2.31 [95% CI 1.54, 3.45]) was associated with poor glycemic control (mean HbA(1c) > 8.5%). Increased risk of diabetic complications was observed in patients with comorbid neurodevelopmental disorders (HRadjusted 1.72 [95% CI 1.21, 2.44] for nephropathy, HRadjusted 1.18 [95% CI 1.00, 1.40] for retinopathy) and patients with ADHD (HRadjusted 1.90 [95% CI 1.20, 3.00] for nephropathy, HRadjusted 1.33 [95% CI 1.07, 1.66] for retinopathy). Patients with intellectual disability have a particularly higher risk of nephropathy (HRadjusted 2.64 [95% CI 1.30, 5.37]). Conclusion: Comorbid neurodevelopmental disorders, primarily ADHD and intellectual disability, were associated with poor glycemic control and a higher risk of diabetic complications in childhood-onset type 1 diabetes.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Kuja-Halkola, R.Karolinska Institutet (författare)
  • Larsson, Henrik,1975-Karolinska Institutet,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden; School of Medical Sciences, Örebro University, Örebro, Sweden(Swepub:oru)hiln (författare)
  • Lichtenstein, P.Karolinska Institutet (författare)
  • Ludvigsson, Jonas F.,1969-Karolinska Institutet(Swepub:oru)jsln (författare)
  • Svensson, Ann-Marie,1961Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; School of Health and Social Science, Halmstad University, Halmstad, Sweden,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden(Swepub:gu)xsannh (författare)
  • Gudbjörnsdottir, Soffia,1962Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden(Swepub:gu)xgudso (författare)
  • Tideman, Magnus,1959-Högskolan i Halmstad,Wigforss-gruppen(Swepub:hh)mati (författare)
  • Serlachius, E.Karolinska Institutet (författare)
  • Butwicka, A.Karolinska Institutet (författare)
  • Karolinska InstitutetInstitutionen för medicinska vetenskaper (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Clinical Endocrinology & MetabolismCary, NC : The Endocrine Society106:110021-972X1945-7197

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy